DHR - Danaher Corp.
Close
269.31
2.290 0.850%
Share volume: 4,600,013
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$267.02
2.29
0.86%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-29 | 2023-12-31 | 2024-03-29 | 2024-06-28 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-20 | 2023-02-22 | 2023-04-25 | 2023-07-25 | 2023-10-24 | 2024-02-21 | 2024-04-23 | 2024-07-23 | |
| Assets | |||||||||
| Total Assets | 81.030 B | 84.350 B | 85.040 B | 84.902 B | 87.734 B | 84.488 B | 83.402 B | 78.555 B | |
| Current Assets | 14.250 B | 15.883 B | 16.532 B | 17.461 B | 21.205 B | 13.937 B | 14.372 B | 9.609 B | |
| Inventories | 3.236 B | 3.110 B | 3.383 B | 3.183 B | 3.024 B | 2.594 B | 2.645 B | 2.671 B | |
| Other Current Assets | 1.455 B | 1.860 B | 1.457 B | 1.504 B | 1.703 B | 1.557 B | 1.317 B | 1.266 B | |
| Short Term Investments | 1.455 B | 1.860 B | 1.457 B | 1.504 B | 1.703 B | 1.557 B | 1.317 B | 1.266 B | |
| Total Receivables | 4.409 B | 4.918 B | 4.313 B | 4.199 B | 4.201 B | 3.922 B | 3.379 B | 3.298 B | |
| Current Cash | 5.150 B | 5.995 B | 7.379 B | 8.575 B | 12.277 B | 5.864 B | 7.031 B | 2.374 B | |
| Total Non-current Assets | 66.780 B | 68.467 B | 68.508 B | 67.441 B | 66.529 B | 70.551 B | 69.030 B | 68.946 B | |
| Property Plant Equipment | 3.719 B | 3.956 B | 4.065 B | 4.176 B | 4.302 B | 4.553 B | 4.562 B | 4.643 B | |
| Other Assets | 4.846 B | 4.133 B | 4.611 B | 4.372 B | 4.286 B | 3.405 B | 3.734 B | 3.953 B | |
| Intangible Assets | 19.964 B | 20.300 B | 19.976 B | 19.317 B | 18.786 B | 20.746 B | 19.888 B | 19.545 B | |
| Goodwill | 38.251 B | 39.752 B | 39.856 B | 39.576 B | 39.155 B | 41.608 B | 40.846 B | 40.805 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 81.030 B | 84.350 B | 85.040 B | 84.902 B | 87.734 B | 84.488 B | 83.402 B | 78.555 B | |
| Total liabilities | 34.045 B | 34.268 B | 33.562 B | 33.186 B | 35.327 B | 31.002 B | 29.960 B | 28.658 B | |
| Total current liabilities | 8.002 B | 8.389 B | 8.730 B | 8.404 B | 9.367 B | 8.274 B | 7.778 B | 6.701 B | |
| Accounts Payable | 2.191 B | 2.296 B | 2.081 B | 1.956 B | 1.894 B | 1.766 B | 1.679 B | 1.645 B | |
| Other liabilities | 7.493 B | 5.922 B | 6.563 B | 6.489 B | 6.439 B | 5.063 B | 5.760 B | 5.643 B | |
| Current long term debt | 705.000 M | 591.000 M | 1.571 B | 1.590 B | 2.547 B | 1.695 B | 1.746 B | 701.000 M | |
| Long term debt | 18.542 B | 19.086 B | 18.261 B | 18.285 B | 19.513 B | 16.707 B | 16.417 B | 16.309 B | |
| Other liabilities | 7.493 B | 5.922 B | 6.563 B | 6.489 B | 6.439 B | 5.063 B | 5.760 B | 5.643 B | |
| Minority interest | 8.000 M | 8.000 M | 8.000 M | 8.000 M | 8.000 M | 4.000 M | 5.000 M | 5.000 M | |
| Total Shareholder equity | 46.985 B | 50.082 B | 51.478 B | 51.716 B | 52.407 B | 53.486 B | 53.442 B | 49.897 B | |
| Common stock | 728.500 M | 728.900 M | 729.400 M | 737.300 M | 834.043 M | 457.519 M | 740.600 M | 737.600 M | |
| Retained earnings | 37.177 B | 39.205 B | 40.437 B | 41.344 B | 42.272 B | 41.074 B | 41.962 B | 42.673 B |